MedWatch

Pfizer gives Danish PM cold shoulder: rejects idea of starting vaccine production in Denmark

Although three of the world's largest pharmaceutical companies have expressed interest in establishing vaccine production facilities in Denmark, Pfizer is not interested in working with the Danish authorities.

Photo: Pool/Reuters/Ritzau Scanpix

Although the Pfizer/Biontech vaccine is the most widely used covid-19 vaccine in Denmark, it does not look like the companies will be establishing vaccine production facilities in the country.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs